Difficulty: Medium
Average Score: 71%
Practice
The following are 1st line anti-tuberculous drugs except:
Correct answer
B
Rationale
In the context of chemotherapy drugs for tuberculosis treatment, the correct answer is B) Cycloserine, as it is not a first-line anti-tuberculous drug. First-line drugs are the primary medications used to treat tuberculosis due to their efficacy and safety profile. Isoniazid, Rifampicin, and Ethambutol are all considered first-line drugs for tuberculosis treatment.
Isoniazid is a key first-line drug that inhibits mycolic acid synthesis in the cell wall of Mycobacterium tuberculosis. Rifampicin acts by inhibiting RNA synthesis in the bacteria, making it another essential first-line drug. Ethambutol works by disrupting the synthesis of the cell wall, making it an effective first-line drug.
Cycloserine is considered a second-line drug for tuberculosis treatment due to its potential side effects and the emergence of resistance when used as a first-line treatment. It is typically reserved for cases where first-line drugs have failed or in the presence of drug-resistant strains.
In an educational context, understanding the distinction between first-line and second-line drugs in tuberculosis treatment is crucial for healthcare professionals managing patients with tuberculosis. Knowing the mechanisms of action and appropriate use of each drug helps in providing effective treatment while minimizing the development of drug resistance. This knowledge is essential for clinical decision-making and ensuring positive patient outcomes in tuberculosis management.
Isoniazid is a key first-line drug that inhibits mycolic acid synthesis in the cell wall of Mycobacterium tuberculosis. Rifampicin acts by inhibiting RNA synthesis in the bacteria, making it another essential first-line drug. Ethambutol works by disrupting the synthesis of the cell wall, making it an effective first-line drug.
Cycloserine is considered a second-line drug for tuberculosis treatment due to its potential side effects and the emergence of resistance when used as a first-line treatment. It is typically reserved for cases where first-line drugs have failed or in the presence of drug-resistant strains.
In an educational context, understanding the distinction between first-line and second-line drugs in tuberculosis treatment is crucial for healthcare professionals managing patients with tuberculosis. Knowing the mechanisms of action and appropriate use of each drug helps in providing effective treatment while minimizing the development of drug resistance. This knowledge is essential for clinical decision-making and ensuring positive patient outcomes in tuberculosis management.